Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil

Pereira1,a, Carlos Alberto de Castro; Baddini-Martinez2,b, José Antonio; Baldi3,c, Bruno Guedes; Jezler4,d, Sérgio Fernandes de Oliveira; Rubin5,e, Adalberto Sperb; Alves6,f, Rogerio Lopes Rufino; Zonzin7,g, Gilmar Alves; Quaresma8,h, Manuel; Trampisch9,i, Matthias; Rabahi10,j, Marcelo Fouad

doi:http://dx.doi.org/10.1590/1806-3713/e20180414

11221
Views

Back to summary

Open Access

Peer-Reviewed
Artigo Original

Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil

Segurança e tolerabilidade de Nintedanibe em pacientes com fibrose pulmonar idiopática no Brasil

Carlos Alberto de Castro Pereira1,a, José Antonio Baddini-Martinez2,b, Bruno Guedes Baldi3,c, Sérgio Fernandes de Oliveira Jezler4,d, Adalberto Sperb Rubin5,e, Rogerio Lopes Rufino Alves6,f, Gilmar Alves Zonzin7,g, Manuel Quaresma8,h, Matthias Trampisch9,i, Marcelo Fouad Rabahi10,j

DOI: http://dx.doi.org/10.1590/1806-3713/e20180414

How to cite this article

Pereira1 CAC, a , Baddini-Martinez2 JA, b , Baldi3 BG, c , et al. Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil. J Bras Pneumol. 2019;45(5):e20180414